Login / Signup

COL1A1::PDGFB fusion-associated uterine fibrosarcoma: A case report and review of the literature.

Simone RotaAndrea FranzaChiara FabbroniBiagio PaoliniFrancesca Gabriella GrecoAlessandra AlessiBarbara PadovanoPaolo CasaliRoberta Sanfilippo
Published in: Cancer reports (Hoboken, N.J.) (2024)
COL1A1::PDGFB fusion-associated uterine fibrosarcoma is an extremely rare mesenchymal neoplasm. In a case we present herein, we treated a patient with imatinib as first-line medical therapy. The patient is currently in complete remission after 37 months from treatment start. To the best of our knowledge, this represents a unique observation. We also provide a detailed literature review of the published cases so far. Prospective case series are needed to further understand the natural history of these tumors and optimize treatment strategies.
Keyphrases
  • case report
  • healthcare
  • stem cells
  • low grade
  • disease activity
  • systemic lupus erythematosus
  • replacement therapy
  • mesenchymal stem cells
  • high grade